Cephalon pays $30M to license lupus drug

Cephalon Inc. of Frazer said today that it will pay $30 million to ImmuPharma P.L.C. for licensing rights to ImmuPharma's drug Lupuzor, an investigational treatment for systemic lupus erythematosus.